Overview
Emmanuelle Verger practices practicing medicine in Paris, France.
Ms. Verger is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Polycythemia Vera, and Myelofibrosis.
She is actively involved in clinical research, co-authoring 30 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Emmanuelle Verger
Is Emmanuelle Verger a top-rated expert for Myeloproliferative Neoplasms (MPN)?
MediFind is an objective health platform that identifies experts based on real-world data. Emmanuelle Verger is classified as an Distinguished expert for Myeloproliferative Neoplasms (MPN), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Emmanuelle Verger participate in research or clinical trials?
Yes. Emmanuelle Verger has published 30 articles and abstracts on conditions like Myeloproliferative Neoplasms (MPN). You can view a list of Emmanuelle Verger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Myeloproliferative Neoplasms (MPN)Ms. Verger isDistinguished. Learn about Myeloproliferative Neoplasms (MPN).
- Advanced
- Essential ThrombocythemiaMs. Verger isAdvanced. Learn about Essential Thrombocythemia.
- MyelofibrosisMs. Verger isAdvanced. Learn about Myelofibrosis.
- Polycythemia VeraMs. Verger isAdvanced. Learn about Polycythemia Vera.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Verger isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Blood ClotsMs. Verger isExperienced. Learn about Blood Clots.
- Deep Vein ThrombosisMs. Verger isExperienced. Learn about Deep Vein Thrombosis.
- LeukemiaMs. Verger isExperienced. Learn about Leukemia.
- Mesenteric Venous ThrombosisMs. Verger isExperienced. Learn about Mesenteric Venous Thrombosis.
- Myelodysplastic Syndrome (MDS)Ms. Verger isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- ThrombophlebitisMs. Verger isExperienced. Learn about Thrombophlebitis.